CincyTech

We are proud to partner with Cincinnati Children's advancing groundbreaking medical research. 🌟 KME-0584, a small-molecule drug developed under the leadership of Dr. Daniel Starczynowski, represents a major milestone in drug discovery at Cincinnati Children's. It offers hope to patients battling relapsed/refractory AML and high-risk MDS. From concept to IND filing, this achievement showcases the power of collaboration. A special nod to Kurome Therapeutics, Inc., National Center for Advancing Translational Sciences (NCATS), and the brilliant researchers who made this possible. Together, we’re transforming innovation into lifesaving treatments. Read more about this incredible journey in the Research Horizons Science Blog below ⬇️ #DrugDevelopment #Innovation #BiotechStartup #CancerResearch #CincinnatiChildrens #AML #MDS

CincyTech Partner Ashley Keating will join Alex Lirtsman of CorralData and Shashank Saxena of SIERRA Ventures at TechCon SoCal this January for an engaging discussion on mastering the transition beyond founder-led sales. Take a sneak peek into what's in store for TechCon SoCal this year: https://lnkd.in/e2J_Uxxr Make sure to secure your seat now: https://lnkd.in/gHU4PfJC #TechConSoCal2025 #GTM #VC #VentureCapital

🎉 Congratulations to Jim Anderson on being named a Great Living Cincinnatian! 🎉 As a founding board member of CincyTech and an influential leader in shaping growth across healthcare, innovation, and the broader business community in Cincinnati, Jim has left an indelible mark on our region. His vision, dedication, and commitment to advancing economic development and fostering a spirit of collaboration continue to inspire us all. CincyTech—and Cincinnati as a whole—have benefited immensely from Jim's leadership and forward-thinking approach. His recognition as a Great Living Cincinnatian is well-deserved and a testament to his impactful legacy. Congratulations, Jim! 👏 james anderson To read more about Jim, his story, and his history with Cincinnati click here: https://lnkd.in/dGKFKTn5

Make sure to listen to Project Medtech's episode with CincyTech CEO & President Emma Scharfenberger Off! You'll learn more about her journey as an M&A lawyer and take a deeper dive into the importance of a board for your company, how to best leverage your board and more.

Check out episode 201 of the Project Medtech podcast! 🎙️ CincyTech CEO & President Emma Scharfenberger Off and Duane Mancini, M. Sc. dive into Emma's journey as an M&A lawyer, explore what CincyTech is all about, and discuss key topics like leveraging your board, decision-making in startups, bridge rounds, creating value, and so much more. Listen here: https://lnkd.in/eUdJqM4U This episode is brought to you by Rook Quality Systems and Baginski Wegner and Company (BW&CO).

ICYMI: We launched CardioFlux to the Cincinnati community right before the holidays, and have been so encouraged by the response and early successes that the program has yielded. My own recent experiences: August 2024: My CardioFlux score (peak marathon conditioning) represents my trained baseline. I arrived at this with an optimal training load (i.e. 4 days of Zone 2 and 1-2 V02 max workouts per week), optimal sleep (averaged 7 hrs 32 mins in the preceding 90 days) and decent nutrition (although definitely an area of improvement for future training cycles) November 2024: Less than 70 days after the marathon, combined with illness, complete detraining and a tremendous amount of work travel, I was unsurprised to re-test on CardioFlux and see a 10 point decrease, well outside of the bounds of my day to day score variability (i.e. a real loss of cardiac fitness). This can also be seen on the trendlines image that shows almost all of my heart health parameters deteriorating during this detraining window. December 2024: I'm back on the grind again, and my goal is to boost my baseline past 75 and into the 80s. Early evidence of this possibility appears...promising. So whether you're training for a marathon, trying out a new diet, adjusting your sleep schedule or trying to make changes related to daily stress, come try us out and let us help you optimize your heart health to achieve your goals! Join us: www.cardioflux.com

#RSNA2024 starts tomorrow! Stop by and see the Ascent3T Neonatal MRI System at booth 6351 in the North Hall. It is a significant advancement in neonatal imaging and is set to transform the way healthcare professionals diagnose and treat newborns. Note: The Ascent3T Neonatal MRI System is not commercially available in any country. This product is not cleared for clinical use in the United States. #RSNA2024 #RSNA #neonatalMRI #forthebabies

We are excited to welcome Eric Baumgardner as a new board member and Logan Hille as Life Sciences Analyst at CincyTech! Eric brings decades of expertise in corporate finance, strategic investments, and business development, including leadership roles at Western & Southern Financial Group and Procter & Gamble. Logan, with a Ph.D. in Biological and Biomedical Sciences from Harvard, adds deep technical insight into life sciences, with a focus on gene-editing technologies and commercialization of groundbreaking research. Together, they enhance our mission to invest in innovative intellectual property and accelerate technologies that disrupt markets and improve global health. Read more: https://lnkd.in/eNHcwyFE

✨ Who would’ve guessed? Cincinnati’s old Sears Department Store is now buzzing as a hub for innovation! 💡 Welcome to the UC 1819 Innovation Hub—where history meets creativity and collaboration. So, what sets us apart? 🌟 Corporate Innovation: Connect with five Fortune 500 companies & leading mid-tier businesses 🚀 Venture Capital: Tap into 4 venture funds fueling growth ⚙️ Creation: Explore a world-class Makerspace 🎮 Play: Dive into our 5,000 sq. ft. Esports Innovation Lab 🌱 Startups: Join a growing list of thriving startups in residence Stop by to connect in person or check out our offerings online: https://lnkd.in/gPjd2YSJ Tony Almaguer #Innovation #Entrepreneurship #UC1819 #Cincinnati #1819InnovationHub #Makerspace #Collaboration #StartupCincy #Cincinnati #CincinnatiInnovationDistrict #VentureFunds #VentureStartups #Fortune500

We’re excited to announce the appointment of five incredible leaders to the OLS Board of Directors! These new members bring diverse expertise from across the life sciences industry to guide OLS into 2025 and beyond: 🔹 Allyson Blandford (Amgen) 🔹 Dr. Paco Herson (The Ohio State University) 🔹 Greg Kimmel (Battelle) 🔹 Liza Lewis, SHRM-CP (Forge Biologics) 🔹 Emma Scharfenberger Off (CincyTech) “OLS is proud to have these dynamic leaders join our distinguished boards, adding to the expertise we are excited to tap into as we continue to deliver for our members and push the life sciences industry forward in our state.” - Eddie Pauline, MBA, OhioCED, president and CEO of OLS. Read the full release: https://lnkd.in/gYmQPyv3 #OhioLifeSciences #Leadership #Innovation